The Corona Remedies IPO is priced between ₹1,008 to ₹1,062 per share, with subscriptions from December 8 to 10. The firm aims to raise ₹655.37 crore through an Offer for Sale. Share allocation will occur on December 11 and listing on BSE and NSE is expected on December 15.